Skip to content

Anxiety: all studies

Page 119 of 769: studies 1,181 to 1,190 of 7,689, newest first. Back to the anxiety overview

Research

Mindfulness-based cognitive therapy on bereavement grief: Alterations of resting-state network connectivity associate with changes of anxiety and mindfulness.

Human Brain Mapping October 17, 2020 Feng-Ying Huang, Ai-Ling Hsu, Yi-Ping Chao et al.

Bereavement, the experience of losing a loved one, is one of the most catastrophic but inevitable events in life. It causes grief and intense depression-like sadness. Recent studies have revealed the effectiveness and proficiency of mindfulness-based cognitive therapy (MBCT) in emotional regulation among bereavement populations. MBCT improves the well-being of the bereaved by enhancing...

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Journal of Psychopharmacology October 11, 2020 Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz et al. 19 citations

Background: Individuals meeting criteria for treatment-resistant depression (TRD) are differentially affected by high levels of anxiety symptoms. Aims: There is a need to identify the efficacy of novel rapid-onset treatments in adults with mood disorders and comorbid anxious-distress. Methods: This study included patients with treatment-resistant major depressive disorder (MDD) or bipolar...

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

Journal of Translational Medicine October 2, 2020 Lara Sharpe, Justin Sinclair, Andrew Kramer et al. 122 citations

BACKGROUND: -tetrahydrocannabinol (THC) has been associated with an anxiogenic response, while anxiolytic activity has been attributed mainly to cannabidiol (CBD). In animal studies, the effects of THC are highly dose-dependent, and biphasic effects of cannabinoids on anxiety-related responses have been extensively documented. A more precise assessment is required of both the anxiolytic and...

Bad dreams, bedtime anxiety, and trait anxiety in school-aged children

Somnologie: Schlafforschung und Schlafmedizin September 25, 2020 Michael Schredl 3 citations

Abstract Background and objectives Occasional nightmares (distressing dreams that awaking the sleeper) and bad dreams (distressing dreams that do not awaking the sleeper) are very common in children and adolescents. About 5% of children experience frequent nightmares (once a week or more often) and the question arises as to what factors contribute to significant nightmare distress which is...

Hippocampal circuits underlie improvements in self‐reported anxiety following mindfulness training

Brain and Behavior September 18, 2020 Gunes Sevinc, Jonathan Greenberg, Britta K. Hölzel et al. 24 citations

Abstract Introduction Mindfulness meditation has successfully been applied to cultivate skills in self‐regulation of emotion, as it employs the unbiased present moment awareness of experience. This heightened attention to and awareness of sensory experience has been postulated to create an optimal therapeutic exposure condition and thereby improve extinction learning. We recently demonstrated...

Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials

Biomedicines September 5, 2020 Ana Sofia Vargas, Ângelo Luís, Mário Barroso et al. 121 citations

Psilocybin is a naturally occurring tryptamine known for its psychedelic properties. Recent research indicates that psilocybin may constitute a valid approach to treat depression and anxiety associated to life-threatening diseases. The aim of this work was to perform a systematic review with meta-analysis of clinical trials to assess the therapeutic effects and safety of psilocybin on those...

DOI: 10.3390/biomedicines8090331 (opens in new tab) Psilocybin Anxiety Context archaeology Beck depression inventory +6

Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies.

BMC Psychiatry August 26, 2020 Ana Maria Raymundi, Thiago R Da Silva, Jeferson M B Sohn et al.

Posttraumatic stress disorder (PTSD) may stem from the formation of aberrant and enduring aversive memories. Some PTSD patients have recreationally used Cannabis, probably aiming at relieving their symptomatology. However, it is still largely unknown whether and how Cannabis or its psychotomimetic compound Δ9-tetrahydrocannabinol (THC) attenuates the aversive/traumatic memory outcomes. Here, we...

The Effect of Mindfulness Therapy on students anxiety in process of conducting research paper at the Institute of Health Science Wira Medika Bali

Healthy-Mu Journal August 16, 2020 Sang A. Kt. Candrawati, Ni Komang Sukraandini, Putu Gede Subhaktiyasa

Students are individuals who are studying well in tertiary institutions. During the academic process, students will complete the final project at the undergraduate level of the thesis called the final student. Students must continue the final project to complete their academic education. One problem that arises in the final student is anxiety. Anxiety is an emotional response that arises due to...

Psilocybin-Assisted Psychotherapy: Treating Depression and Anxiety with Mushrooms

August 5, 2020 Sofia Beck 1 citation

Depression and anxiety are debilitating mental health conditions that affect a large portion of the United States. Current pharmacological treatments for these disorders require daily administration, are associated with a number of side effects, and can be ineffective for some. Emerging evidence in novel treatment options may necessitate a shift toward how we treat these psychiatric disorders.